Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma

doi:10.4254/wjh.v16.i12.1480

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (424)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

242

Figures (1-4)

Tables (1-3)

Sum=351

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=51

Dec 27, 2024 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Dec 27, 2024; 16(12): 1480-1492
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1480

Full Size Figure Download Figure

Figure 2 Alterations in whole gene expression profiling. A: Microarray analysis of the expression levels of a total of 28000 genes between rat hepatocellular carcinoma and normal control liver samples by false color imaging; B: The scatter plot of gene alterations between rat hepatocellular carcinoma and normal control livers is shown in a volcano plot; C: Gene upregulation in the cell cycle in hepato- carcinogenesis model rats. NC: Normal control; HCC: Hepatocellular carcinoma.

Citation: Yang JL, Yang J, Fang RF, Sai WL, Yao DF, Yao M. Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma. World J Hepatol 2024; 16(12): 1480-1492
URL: https://www.wjgnet.com/1948-5182/full/v16/i12/1480.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i12.1480